ggwpq, I think Vascepa is a unique drug. It does not just correct a single problem like most drugs. Because of its anti-inflammatory properties, it has virtually unlimited applications if properly utilized. Obviously Amarin cannot take advantage of that. But a large BP could.
Not to mention, the marketing strength of a BP can help with docs and insurers tremendously.
News 
Market Data 
Discover 
